EPISODE · Feb 22, 2022 · 7 MIN
In conversation with... Alexandra Durr
from Listen to The Lancet Neurology · host The Lancet
Alexandra Durr (Paris Brain Institute, Pitié-Salpêtrière Paris, France) discusses the ATRIL study, a randomised trial of riluzole in patients with spinocerebellar ataxia type 2, which is published in the March issue of The Lancet Neurology.
NOW PLAYING
In conversation with... Alexandra Durr
0:00
7:55
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Listen to The Lancet Neurology?
This episode is 7 minutes long.
When was this Listen to The Lancet Neurology episode published?
This episode was published on February 22, 2022.
What is this episode about?
Alexandra Durr (Paris Brain Institute, Pitié-Salpêtrière Paris, France) discusses the ATRIL study, a randomised trial of riluzole in patients with spinocerebellar ataxia type 2, which is published in the March issue of The Lancet Neurology.
Can I download this Listen to The Lancet Neurology episode?
Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!